LSI USA '24
Learn about the emerging companies, finance trends, and strategic drivers impacting the global medtech industry.
Our Next Event → LSI USA '24 in Dana Point, California on March 18-22.
Hear from the LSI Alumni community on why they attend (and come back to) LSI events.
Galen Robotics is a Digital-Surgery-as-a-Service (DSaaS) combining the power of a new microsurgery platform with a system of big data analytics and machine learning to provide advanced surgical assistance in performing delicate or intricate procedures.
We Venture Capital is investing globally in diagnostics start-ups, as well as digital solutions and biotechnology in the diagnostics arena.
Opal Ventures is backing startups that empower people to live healthier, happier, and more productive lives.
TVM Capital Life Science is one of the transatlantic Venture Capital pioneers with teams based in North America and Europe.
Velentium is a professional engineering firm specializing in the design and manufacturing of therapeutic and diagnostic active medical devices.
Medtronic's mission is to contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life.
Alluvia Studio is a medtech strategic marketing agency that helps companies clearly define the immense value of their patient care innovations.
This special panel features Manny Villafaña, a highly successful Medtech executive with seven IPO's, who discusses his current venture, his start in the med device world, and the stories that improved the lives of patients globally.
Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms.
Wander Health's digital platform is designed to connect travelers with English-speaking healthcare providers across the globe.
In this discussion, the panelists provide a comprehensive perspective from all sides of an acquisition, offering a roadmap for navigating the complexities of these business transactions.
AVVie is developing a novel, minimally invasive implant to address mitral valve regurgitation.
With AI and Large Language Models currently experiencing widespread implementation, this timely panel reviews their impact and opportunity in Healthcare.
Field Medical is developing a next-generation pulsed field ablation (PFA) solution for the treatment of cardiac arrhythmia.
BrightHeart is developing an artificial intelligence (AI) software company focused on improving the detection of congenital heart defects from fetal ultrasounds.
This panel explores the impact of the digital transformation in healthcare and hospitals, while also discussing the opportunities and challenges presented.
Through this panel, our panelists showcase Barcelona's Life Science ecosystem, delving into its strengths, weaknesses, and unique advantages in fostering innovation.
Manny Villafaña joined Scott Pantel for a spotlight interview at LSI Europe ‘23 Emerging Medtech Summit to discuss his current project, Medical 21, as well as some personal notes as to why he's still innovating in a notoriously difficult space.
Pixium is a bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.
The panelists discuss the process and pitfalls of operating, investing in, or commercializing a digital health/therapeutics startup.
This panel aims to guide pre-commercial and commercial stage startups in successfully entering their first hospital and how to navigate the path to further expansion.
Moon Surgical is developing a surgical robot to assist with laparoscopic surgeries. The system will feature a modular platform, computer vision, and haptics to augment the capabilities of surgeons.
This 'Tale of Two Entrepreneurs' explores the shift from an entrepreneurial background to venture capital, while highlights its significance in building an early-stage VC.
This discussion will review and assess the evolving trends within the healthtech, medtech, and biotech landscapes, exploring strategies to bolster these ecosystems amidst the prevailing investment climate.
During this insightful panel, industry experts explore the obstacles obstructing the aggregation of patient and EHR data, despite its potential to drive innovation and personalize healthcare.
Vivasure's PerQseal closure device is touted as the first fully bioabsorbable, sutureless and entirely synthetic option to close large-bore arteriotomies that result from percutaneous transcatheter procedures.
Intuitive Ventures invests in and accelerates the digital, therapeutic, diagnostic, and device ecosystems of minimally invasive care.
This panel talks about the transformative potential of the next generation of robotics and digital surgery, moving beyond mere gadgetry to unlock substantial real-world value.